Crescent Capital BDC (NASDAQ:CCAP) Given New $19.00 Price Target at Wells Fargo & Company

Crescent Capital BDC (NASDAQ:CCAPGet Free Report) had its price objective hoisted by equities research analysts at Wells Fargo & Company from $18.00 to $19.00 in a research report issued on Wednesday,Benzinga reports. The brokerage presently has an “equal weight” rating on the stock. Wells Fargo & Company‘s target price points to a potential downside of 2.71% from the stock’s current price.

Separately, Keefe, Bruyette & Woods upped their price objective on Crescent Capital BDC from $19.00 to $20.00 and gave the company an “outperform” rating in a report on Monday, November 25th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, Crescent Capital BDC presently has a consensus rating of “Moderate Buy” and an average target price of $19.33.

Check Out Our Latest Report on CCAP

Crescent Capital BDC Stock Up 1.3 %

NASDAQ CCAP opened at $19.53 on Wednesday. The stock’s 50 day moving average is $19.38 and its two-hundred day moving average is $18.77. Crescent Capital BDC has a 1-year low of $15.91 and a 1-year high of $20.03. The company has a market capitalization of $723.82 million, a price-to-earnings ratio of 7.66 and a beta of 0.81. The company has a current ratio of 1.26, a quick ratio of 1.26 and a debt-to-equity ratio of 1.14.

Crescent Capital BDC (NASDAQ:CCAPGet Free Report) last issued its quarterly earnings results on Tuesday, November 12th. The company reported $0.64 EPS for the quarter, topping the consensus estimate of $0.57 by $0.07. Crescent Capital BDC had a net margin of 47.06% and a return on equity of 12.20%. The company had revenue of $51.63 million during the quarter, compared to analysts’ expectations of $48.76 million. During the same quarter in the previous year, the company earned $0.59 EPS. Equities analysts forecast that Crescent Capital BDC will post 2.43 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Crescent Capital BDC

Several institutional investors have recently modified their holdings of CCAP. Montag A & Associates Inc. acquired a new position in shares of Crescent Capital BDC during the fourth quarter worth about $35,000. Point72 Asset Management L.P. acquired a new position in Crescent Capital BDC during the 2nd quarter worth approximately $90,000. Cubist Systematic Strategies LLC acquired a new position in Crescent Capital BDC during the 2nd quarter worth approximately $346,000. Pettinga Financial Advisors LLC grew its stake in shares of Crescent Capital BDC by 95.8% during the 3rd quarter. Pettinga Financial Advisors LLC now owns 29,017 shares of the company’s stock worth $537,000 after acquiring an additional 14,200 shares in the last quarter. Finally, Redhawk Wealth Advisors Inc. acquired a new stake in Crescent Capital BDC in the 4th quarter valued at $659,000. Institutional investors own 49.46% of the company’s stock.

Crescent Capital BDC Company Profile

(Get Free Report)

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

Recommended Stories

Analyst Recommendations for Crescent Capital BDC (NASDAQ:CCAP)

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.